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1. Introduction
Once administered into the human body, 
a drug faces various challenges before 
reaching its target location. Drug delivery 
systems such as liposomes or polymer 
nano particles/micelles are utilized to pro-
tect the drug but any circulating system 
is also challenged to a certain degree by 
excretion and/or biotransformation in 
the human body.[1] Control of pharma-
cokinetics and pharmacodynamics is par-
ticularly important and challenging when 
administering readily metabolized com-
pounds. Another important aspect for 
drug delivery systems is the drug release 
kinetics. As intrinsically dynamic systems, 
drug-loaded polymer micelles often face 
the challenge of rapid drug release, which 
then associates with proteins present in the 
blood stream[2,3]; is excreted, or taken up in 
tissue other than desired one, which may 
be detrimental for the therapeutic effi-
cacy.[4] To enable a more sustained release, 
active pharmaceutical ingredients (API) 
can be embedded in drug depots from 
which the drug is released continuously, maintaining a high local 
drug concentration in the surrounding tissue over an extended 
period of time.[5–7] Ideally, the depot formulation not only pro-
longs drug release, but also protects the incorporated compound 
from premature degradation. Besides micro fabricated devices,[8] 
metallic implants,[9] organogels[10] or electrospun fibers,[11] 
hydrogels[12] are considered promising drug depot matrices. 
Hydrogels are three-dimensionally cross-linked networks of 
water-soluble polymers.[13,14] Due to their high water content, 
hydrogels are generally regarded as highly biocompatible.[15,16] 
Drug-loaded hydrogels as depot formulations showed great 
therapeutic potential in various scenarios in vitro[17–21] as well as 
in vivo.[22–29] In situ forming or injectable hydrogels are of par-
ticular interest due to their ease of application without surgical 
needs.[30–33] In this context, physically crosslinked thermogelling 
hydrogels based on hydrophobic interactions are advantageous, 
as they can be injected in the cold, liquid state to solidify at body 
temperature without the addition of crosslinkers or any other 
external trigger.[34,35] Various compounds including PTX,[36] 
interleukin-2,[37] topotecan,[38] doxorubicin,[25] or fluorouracil[39] 
have been incorporated into thermogelling hydrogels to prolong 
drug release as well as enhance retention at tumor site.
Hydrogel-based drug depot formulations are of great interest for therapeutic 
applications. While the biological activity of such drug depots is often charac-
terized well, the influence of incorporated drug or drug-loaded micelles on the 
gelation properties of the hydrogel matrix is less investigated. However, the 
latter is of great importance from fundamental and application points of view 
as it informs on the physicochemical interactions of drugs and water-swollen 
polymer networks and it determines injectability, depot stability, as well as 
drug-release kinetics. Here, the impact of incorporated drug, neat polymer 
micelles, and drug-loaded micelles on the viscoelastic properties of a cyto-
compatible hydrogel is investigated systematically. To challenge the hydrogel 
with regard to the desired application as injectable drug depot, curcumin 
(CUR) is chosen as a model compound due to its very low-water solubility 
and limited stability. CUR is either directly solubilized by the hydrogel or 
pre-incorporated into polymer micelles. Interference of CUR with the temper-
ature-induced gelation process can be suppressed by pre-incorporation into 
polymer micelles forming a binary drug delivery system. Drug release from 
a collagen matrix is studied in a trans-well setup. Compared to direct injec-
tion of drug formulations, the hydrogel-based systems show improved and 
extended drug release over 10 weeks.
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A compound which is particularly challenging to formu-
late—in form of hydrogels or otherwise—is curcumin (CUR). 
A plethora of preclinical studies pointed out the antioxidative,[40] 
cardioprotective,[41] or antitumor[42] activities of the “generally 
recognized as safe” (GRAS; evaluated by United States Food 
and Drug Administration (FDA))[43] compound. Despite a large 
number of clinical trials, it has not been approved as drug for 
human use. Besides potentially troublesome evaluation of pre-
clinical data,[44–47] this is most likely associated with the extremely 
low water solubility of 0.6 mg L−1 (1.6 µm)[48] of CUR as well as 
the molecules’ high susceptibility to degradation, not only in 
water,[49,50] but also to biomedical transformations such as carbon 
chain cleavage, reduction, conjugation with glucuronic acid or 
sulfate in biological media in vitro[51] and in vivo.[52] These issues 
make CUR an interesting model compound to challenge hydro-
gels with respect to their desired application as injectable drug 
depot. Previously, poly(2-oxazoline) (POx) and poly(2-oxazine) 
(POzi)-based drug-delivery vehicles with interesting structure–
property relationships with respect to drug loading and potential 
for parenteral administration of CUR were reported.[53–58] The 
loading capacities (LCs) for CUR in ABA triblock-copolymers 
comprising the same hydrophilic poly(2-methyl-2-oxazoline) 
(PMeOx) corona (= A) and either poly(2-n-butyl-2-oxazoline) 
(PBuOx) (= A-BuOx-A) or (poly(2-n-propyl-2-oxazine) (PPrOzi) 
(= A-PrOzi-A) as hydrophobic blocks ranged from 21.6 wt% to 
54.5 wt%.[53] Although benefits with respect to therapeutic effi-
cacy of intravenously administered, ultra-high loaded A-BuOx-A/
paclitaxel formulations (LC = 45 wt%) and combination formu-
lations of hydrophobic cis-platin prodrug and etoposide or PTX 
have been observed in vivo,[59–63] this might not be true for CUR 
due to its susceptibility to degradation or toxicity at high concen-
trations (not achievable orally). Inspired by CUR-loaded hydro-
gels for cutaneous wound repair[28] or intranasal drug delivery 
to the brain,[64] we wondered, if we could incorporate CUR in a 
recently reported, cytocompatible PMeOx-b-PPrOzi copolymer-
based hydrogel,[65] for subcutaneous or intratumoral injection 
in order to avoid systemic circulation and/or allow prolonged 
release. From a more fundamental and practical point of view, it 
was also interesting to investigate the influence of hydrophobic 
CUR on the viscoelastic properties of a hydrogel that is formed 
based on dynamic hydrophobic interactions. Furthermore, the 
effect of nanoformulated CUR incorporated into the hydrogel 
matrix is of interest. Although drug-loaded poly mer micelles 
incorporated into hydrogel matrices are readily found in the liter-
ature,[17,28,29,66] such systematic investigations of the viscoelastic 
properties of hydrogels containing nanoformulated hydrophobic 
drugs are rare. In addition, to assess the potential as an inject-
able thermogelling drug depot, the CUR-loaded hydrogels were 
injected into a collagen matrix and CUR release quantified.
2. Experimental Section
2.1. Reagents and Solvents
All substances used for the preparation of polymers were pur-
chased from Sigma-Aldrich (Steinheim, Germany) or Acros 
(Geel, Belgium) and were used as received unless otherwise 
stated. Curcumin powder from Curcuma longa (turmeric) 
was purchased from Sigma-Aldrich and analyzed in-house 
(curcumin = 79%; demethoxycurcumin = 17%, bisdemethoxy-
curcumin = 4%; determined by HPLC analysis; Figure S18, 
Supporting Information). Deuterated chloroform (CDCl3) or 
methanol (MeOD) for NMR analysis was obtained from Deu-
tero GmbH (Kastellaun, Germany).
The monomers 2-n-propyl-2-oxazine (nPrOzi), 2-n-butyl-
2-oxazoline (nBuOx) and 2-n-butyl-2-oxazine (nBuOzi) were 
synthesized according to Seeliger et al.[67] (Figures S1–S4, Sup-
porting Information). All substances used for polymerization, 
namely methyl trifluoromethylsulfonate (MeOTf), propargyl 
p-toluenesulfonate, benzonitrile (PhCN), sulfolane and all mon-
omers were refluxed over CaH2 (PhCN was refluxed over P2O5) 
and distilled under argon.
2.2. Polymer Synthesis
The polymerizations and work-up procedures of the ABA tri-
block-copolymers[54] as well as the AB diblock-copolymers[65] 
were described recently and can be found in Figures S5–S16, 
Supporting Information. Briefly, the preparation of block-
copolymers was performed as follows: initiator was added to a 
dried and nitrogen flushed flask and dissolved in the respective 
amount of solvent. The monomer for the first block was added 
and the reaction mixture was heated to 100 °C (2-R-2-oxazoline) 
or 120 °C (2-R-2-oxazine). Reaction progress was controlled by 
FTIR- and 1H-NMR-spectroscopy. After complete monomer con-
sumption, the mixture was cooled to RT and the monomer for 
the second block was added. After complete monomer consump-
tion, the procedure was repeated for the third block in the case of 
ABA triblock-copolymers. After monomer consumption was con-
firmed for the last block, termination was carried out by addition 
of a secondary amine at 50 °C for 4 h. Subsequently, K2CO3 was 
added and the mixture was stirred at 50 °C for 4 h. Precipitates 
were removed by centrifugation and the solvent was removed 
under reduced pressure. The supernatant was transferred into a 
dialysis bag and dialyzed against Millipore water overnight. The 
solution was recovered from the bag and lyophilized.
2.3. Nuclear Magnetic Resonance Spectroscopy
1H-NMR spectra were recorded on a Fourier 300 (300 MHz), 
Bruker Biospin (Rheinstetten, Germany) at 298 K. The spectra 
were calibrated to the signal of residual protonated solvent 
signal (CDCl3: 7.26 ppm). Multiplicities of signals are depicted 
as follows: s, singlet; d, doublet; t, triplet; q, quartet; quin, 
quintet; dt; doublet of triplets; m, multiplet; b, broad.
2.4. Dialysis
Dialysis was performed using Spectra/Por membranes with 
a molecular weight cutoff of 1 kDa (ABA-triblock copoly-
mers) or 8 kD (AB-diblock copolymers) (material: cellulose 
acetate) obtained from neoLab (Heidelberg, Germany). Water 
(Millipore) was renewed after 1 and 4 h, and every 12 h subse-
quently, until end of dialysis.
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2.5. Gel Permeation Chromatography
Gel permeation chromatography (GPC) was performed on 
an Agilent 1260 Infinity System, Polymer Standard Service 
(Mainz, Germany) with either HFIP containing 3 g L−1 potas-
sium trifluoroacetate; precolumn: 50 × 8 mm PSS PFG linear 
M; 2 columns: 300 × 8 mm PSS PFG linear M (particle size 
7 µm) or DMF containing 1 g L−1 LiBr; precolumn: 50 × 8 mm 
PSS GRAM; columns: 30 and 1000 Å 300 × 8 mm PSS GRAM 
(particle size 10 µm) as eluent. The columns were kept at 
40 °C and flow rates were 1.0 mL min−1 (DMF) or 0.7 mL 
min−1 (HFIP). Prior to each measurement, samples were fil-
tered through 0.2 µm PTFE filters, Roth (Karlsruhe, Germany). 
Conventional calibration was performed with PEG standards 
(0.1–1000 kg mol−1) and data were processed with WinGPC 
software.
2.6. CUR-Loaded Polymer Micelles
CUR-loaded polymer micelles were prepared by thin film 
method.[59] Ethanolic polymer (20 g L−1) and CUR (5.0 g L−1) 
stock solutions were mixed in desired ratio. After complete 
removal of the solvent at 50 °C under a mild stream of 
argon, the films were dried in vacuo (≤ 0.2 mbar) for 20 min. 
Subsequently, preheated (37 °C) H2O was added. Complete 
solubilization was facilitated by shaking the solutions at 
1250 rpm at 55 °C for 12 min with a Thermomixer comfort, 
Eppendorf AG (Hamburg, Germany). Non-solubilized drug 
(if any) was removed by centrifugation for 5 min at 9.000 rpm 
with a MIKRO 185 (Hettich, Tuttlingen, Germany). Solubiliza-
tion experiments were performed with three individually pre-
pared samples and results are presented as mean ± standard 
deviation (SD).
CUR quantification was performed by UV–vis absorption 
on a BioTek Eon Microplate Spectrophotometer, Thermo 
Fisher Scientific (MA, USA) using a calibration curve 
obtained with known amounts of CUR (Figure S19, Sup-
porting Information). Samples were prepared in Rotilabo 
F-Type 96 well plates, Carl Roth GmbH & Co. KG (Karlsruhe, 
Germany) at a constant volume of 100 µL. Spectra were 
recorded from 300–600 nm at 25 °C and CUR was quanti-
fied at 428 nm. Prior to UV–vis absorption measurements, 
the aqueous formulations were appropriately diluted with 
ethanol. The following equations were used to calculate LC 
and loading efficiency (LE): 
LE drug
drug, added
m
m
=  (1)
LC drug
drug polymer
m
m m
=
+
 (2)
where mdrug and mpolymer are the weight amounts of solubi-
lized drug and polymer excipient in solution and mdrug,added 
is the weight amount of drug initially added to the disper-
sion. No loss of polymer during micelles preparation was 
assumed.
2.7. CUR-Loaded Hydrogels
CUR-loaded hydrogels were prepared using a modified thin 
film method. Dried CUR/polymer films were dissolved in pre-
cooled (5 °C) H2O (Millipore) and shaken at 1200 rpm at 8 °C 
with a Thermomixer comfort, Eppendorf AG (Hamburg, Ger-
many) until no solids were detectable anymore by visual inspec-
tion (≈6 h). The clear, viscous solutions were used without 
further purification. For CUR quantification, small amounts of 
CUR-loaded hydrogels were sampled and dissolved in ethanol. 
Drug content was determined by UV–vis absorption according 
to Equation (3):
CUR(mg/g) drug
hydrogel ,wet
m
m
=  (3)
where mdrug is the weight amount of solubilized drug and 
mhydrogel,wet is the weight of CUR-loaded hydrogel in the 
wet state. Loading capacity LC was determined according to 
Equation (2). For the determination, three samples were taken 
from the respective hydrogel and measured individually. How-
ever, each hydrogel was prepared once.
2.8. Incorporation of CUR-Loaded Polymer Micelles into 
Hydrogel
Respective amounts of freeze-dried, CUR-loaded polymeric 
micelles were added to a precooled (≈8 °C) aqueous solution 
of the respective hydrogel (20 wt%). The dispersion was gently 
shaken at ≈8 °C until the freeze-dried micelles were completely 
dissolved in the hydrogel solution (≈2 days). The drug contents of 
the clear, highly viscous solutions were determined according to 
Equation (8) and LC was determined according to Equation (2).
2.9. Rheology
Rheological analysis was performed on a Physica MCR 301, 
Anton Paar (Ostfildern, Germany) utilizing a plate–plate geom-
etry (diameter 25 mm). The rheometer was equipped with a 
Peltier element. Prior to temperature-sweep measurements, the 
samples were allowed to equilibrate on the rheometer at 5 °C 
for 3 min. Following this, the temperature was raised linearly 
from 5 to 60 °C at 5 °C min−1. Frequency was 1 Hz and the 
amplitude was 0.5% at 0.5 mm plate–plate distance. Within 
these conditions, the hydrogels (20 wt% in deionized H2O) 
were within their linear viscoelastic region[65] and CUR-loaded 
hydrogels were assumed to be as well.
2.10. HPLC Measurements
CUR-loaded hydrogels were analyzed on a LC-20A Promi-
nence HPLC, Shimadzu (Duisburg, Germany) equipped with 
a system controller CBM-20A, a solvent delivery unit LC-20 AT 
(double plunger), an online degassing unit DGU-20A, an auto-
sampler SIL-20AC, and a SPD-20A UV–vis detector. As sta-
tionary phase, a ZORBAX Eclipse Plus, Agilent (Santa Clara, 
Macromol. Chem.  Phys. 2020, 221, 1900341
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CA, USA) C18 column (4.6 × 100 mm; 3.5 µm) was used. The 
mobile phase was a gradient of H2O/ACN (Figure S18a, Sup-
porting Information) at 40 °C and a flow rate of 1 mL min−1. 
CUR was quantified at 427 nm. Possible degradation products 
were investigated at 220 nm.
2.11. Long-Term Stability Studies
For long-term stability studies, CUR-loaded hydrogels were 
stored in the freezer (≈8 °C). For CUR quantification, small 
amounts of CUR-loaded hydrogels were sampled and dissolved 
in ethanol. Drug content was determined by UV–vis absorption 
at 428 nm. To confirm CUR integrity, small amounts of CUR-
loaded hydrogels were sampled and diluted with ACN/H2O 
= 60/40 (v/v) and characterized by HPLC analysis at 220 and 
427 nm.
2.12. CUR-Release Studies
For CUR-release studies, CUR-loaded hydrogels were injected 
into trans-well inserts (24-well plate, BRANDplates insert 
system, BRAND GmbH & Co. KG, Wertheim, Germany) filled 
with collagen hydrogels at a final concentration of 6 g L−1 as 
reported previously[68] with a Hamilton syringe (injection 
volume: 10 µL). For every sample, three injection of the same 
batch of formulation were placed in individual wells. To ensure 
constant injection depth and position, a 3D-printed scaffold 
was utilized as guidance for the syringe. Prior to injection, 
the CUR-loaded hydrogel filled Hamilton syringe was cooled 
in the freezer (≈8 °C) to ensure liquidity of respective hydro-
gels. Basolateral chamber was filled with 1500 µL PBS and col-
lagen matrix in the apical side was covered with 100 µL PBS. 
At specific time-points mentioned in main text, the solution of 
the basolateral side was removed, freeze-dried and dissolved 
in ethanol. Ethanolic solutions were centrifuged for 10 min at 
9000 rpm in order to avoid scattering from undissolved salts 
from PBS. CUR content of the supernatant was quantified by 
UV–vis absorption at 428 nm and CUR integrity confirmed by 
HPLC analysis at 220 and 427 nm.
3. Results and Discussion
3.1. CUR Solubilization
Whereas A-BuOx-A nanoformulations exhibit CUR LCs compa-
rable to those found in the literature for other polymer amphi-
philes (LC ≈20 wt%[69]), its structural isomer A-PrOzi-A enables 
very high CUR-loadings >50 wt%.[54] The drug formulations 
with these ABA-triblock copolymers are designed for intra-
venous (IV) administration; however, rapid clearance of APIs 
in highly dynamic polymer micelles has been observed.[60] In 
contrast, steady serum concentrations, which can be crucial in 
many applications, could be achieved through the use of sub-
cutaneous depots.[70] In 2017, Lorson et al. reported a POx/
POzi-based reversibly thermogelling hydrogel as cytocompat-
ible bioink.[65] As this polymer comprises the same building 
blocks as A-PrOzi-A but has a different architecture (AB diblock 
vs ABA triblock) and monomer ratio, the effects of solubilized 
CUR on the hydrogel properties (gel temperature, storage/loss 
modulus) are of interest. Hence, CUR was incorporated into 
aqueous solutions of PPrOzi50-b-PMeOx50 (H50) and PPrOzi100-
b-PMeOx99 (H100) (Table 1; for polymer synthesis and charac-
terization, the reader is referred to Figures S12–S16, Supporting 
Information). Such, the influence of the degree of polymeriza-
tion (DP) of both blocks on the solubilization capacity for CUR 
can be assessed.
Although exhibiting the same building blocks as A-PrOzi-
A, both diblocks exhibited much lower LCs for CUR than the 
former as well as compared to A-BuOzi-A and A-BuOx-A. At 
10 g L−1 polymer, only 0.87 g L−1 (LC = 8 wt%) or 0.91 g L−1 
(8.4 wt%) CUR could be solubilized using H50 or H100, respec-
tively (Figure 1a). Increasing the polymer concentration to 
50 g L−1 somehow increased CUR loadings up to 15 wt% 
(CUR = 8.8 g L−1) in the case of H50. Similar shortcoming of 
AB diblock-copolymers compared to the corresponding ABA 
triblock-copolymers with respect to their solubilization capacity 
has been observed before. Whereas A-BuOx-A exhibits LCs up 
to 49 wt% for the water-insoluble drug paclitaxel (PTX), the cor-
responding diblock only enabled PTX-loadings of 17 wt%.[71] 
However, in this case, the DP of the respective blocks were 
similar while in the present case the thermoresponsive block 
has a much higher DP in the diblocks compared to the triblock. 
At ≤50 g L−1, neither H50 nor H100 forms a gel, but apparently, 
the self-assemblies formed -presumably polymersomes-[72] are 
not well suited for CUR solubilization.[65]
The polymer concentrations of 10 and 50 g L−1 were chosen 
to compare the solubilization behavior of H50 or H100 with 
those of the previously reported A-BuOx-A, A-PrOzi-A, and 
A-BuOzi-A. The latter were designed as drug vehicles for intra-
venous administration, for which those moderate polymer 
concentrations are most suitable. In contrast, drug-loaded 
hydrogels find applications often at much higher polymer con-
centrations. Therefore, LC of H100 was also investigated at 
polymer concentrations of 20 wt% at which gelation occurs. 
As H100 already forms a gel <20 °C at this concentration the 
dried drug/polymer films were re-dispersed with water at 
5 °C until no solid particles were detectable anymore by visual 
Macromol. Chem.  Phys. 2020, 221, 1900341
Table 1. Analytical data of investigated block copolymers including the 
yield, molar mass Mn and dispersity Đ.
Compositiona) Polymer ID Yield  
[%]
Mna) Mnb) Mnc) Đc)
[kg mol−1]
PMeOx35-b-PPrOzi20-b-PMeOx35 A-PrOzi-A 67 8.7 9.8* 6.1 1.16
PMeOx35-b-PBuOx20-b-PMeOx35 A-BuOx-A 82 8.6 7.0* 7.2 1.18
PMeOx35-b-PBuOzi20-b-PMeOx35 A-BuOzi-A 67 9.0 9.4* 5.6 1.20
PPrOzi50-b-PMeOx50 H50 75 10.8 10.4** 7.3 1.17
PPrOzi100-b-PMeOx99 H100 89 21.3 20.2** 10.4 1.38
a)According to [M]0/[I]0; b)Obtained by 1H-NMR (*CDCl3; **MeOD); evaluated as 
mean of all relevant signals; c)Obtained by GPC (eluent: DMF, calibrated with PEG 
standards); deviations in molar mass determination between NMR end-group 
analysis and GPC standard calibration can be attributed to the use of PEG-stand-
ards for calibration.[55] Synthesis and characterization of the triblock-[54] as well as 
diblock-copolymers[65] was previously reported.
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inspection (≈6 h). The obtained clear solutions were moderately 
viscous at T ≤ 5 °C and showed an increasing viscosity with 
increasing CUR loading, as per visual inspection. As defined 
volumes could not be easily sampled from the viscous solu-
tions even at T ≤ 5 °C, small amounts of the CUR-loaded hydro-
gels were weighed, and the CUR loading will be defined as the 
ratio of solubilized CUR (mg) with respect to the total weight 
of the hydrogel in the hydrated state (g) (Equation (3)). Loading 
efficiencies (LE) between 75% and 83% and rather high aqueous 
CUR concentrations of up to 23.6 ± 0.5 mg/g (LC = 10.6 wt%) at 
mass concentration of ρ(H100) = 20 wt% (Figure 2a) could be 
obtained. The fact that those high CUR concentrations were fea-
sible using H100 and because H50 only gelled at elevated tem-
perature with (Tgel > 57 °C) or without (Tgel = 40 °C) the addition 
of triblock copolymers (Figure S20, Supporting Information), 
H50 was not investigated further in the present work. It should 
Macromol. Chem.  Phys. 2020, 221, 1900341
Figure 1. Solubilized aqueous CUR concentrations (bars, left axis) and corresponding loading capacities (lines, right axis) in dependence of the CUR 
feed by H50 (black) or H100 (gray) at polymer concentrations of a) 10 or b) 50 g L−1. Data are given as means ± SD (n = 3).
Figure 2. a) Solubilized aqueous CUR concentrations (bars, left axis) and corresponding loading capacities (line, right axis) in dependence of the CUR 
feed by H100 at 20 wt% in H2O. Data are given as means ± SD (n = 3); b) solubilized aqueous CUR concentrations (bars, left axis) and corresponding 
loading capacities (lines, right axis) in dependence of the CUR feed by H100 (20 wt% in H2O) after incorporation of freeze-dried, CUR-loaded micelles 
of either A-BuOx-A (blue), A-BuOzi-A (red), or A-PrOzi-A (black). Amount of polymer within the CUR-loaded micelles was either 25 mg/ghydrogel,wet 
or 50 mg/ghydrogel,wet (green). Each hydrogel was prepared once; however, CUR concentration was quantified with three withdrawn samples each to 
confirm homogeneous CUR distribution and absence of precipitation; c) images of the incorporation of freeze-dried, CUR-loaded micelles (A-PrOzi-A/
CUR = 50/30 g/g) into H100 (20 wt% in H2O). The amounts of A-PrOzi-A and CUR were 50 and 15 mg/g, respectively. Samples were gently shaken 
at 5 °C for 2 days. Illustration of CUR-loaded micelles and (CUR-loaded) gels, are given as a very rough visualization and should not be confused with 
the actual structure of the respective solutions.
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be noted that reproducibility of Tgel of H50 is generally more 
susceptible to batch-to-batch variations compared to H100.[65]
In addition to direct solubilization of CUR with H100, 
freeze-dried CUR nanoformulation of either A-BuOx-A 
(Figure 2b, blue), A-BuOzi-A (red) or A-PrOzi-A (black) were 
incorporated at same CUR feed concentrations of 7.5, 15, and 
30 mg/g. To obtain more detailed insights into the influence of 
the ABA-triblock copolymers, two different triblock concentra-
tions (25 and 50 mg/g) were investigated. Due to the limited 
LC of A-BuOx-A for CUR, highly loaded micelles were only fea-
sible using A-BuOzi-A or A-PrOzi-A. The aqueous solutions of 
H100 (20 wt% in H2O) were precooled to 5 °C and the respec-
tive amount of lyophilized, CUR nanoformulation was added. 
The mixture was shaken at 5 °C for 2–4 days (depending on 
the used polymer and CUR concentration) until a completely 
clear and viscous solution was formed (Figure 2c). Similar to 
the solubilization of neat CUR (Figure 2a), the hydrogels incor-
porating CUR-loaded micelles exhibited excellent LEs >95% 
(Figure 2b) with no visible sign of precipitation.
The CUR-loaded hydrogels showed even higher stability 
than the CUR nanoformulations of, for example, A-PrOzi-
A[54] and drastically prolonged shelf-life with no apparent 
loss of CUR-content even after 22 months of storage in the 
sol-state at 8 °C under the exclusion of light (Figure 3a). 
This is remarkable, as 90% of CUR was reported elsewhere 
to be degraded in water (pH = 7.2; 37 °C) after 30 min.[49,50] 
Although exhibiting high polymer concentrations up to 
25 wt% (H100 = 20 wt% + ABA triblock copolymer = 5 wt%), 
the major component of the CUR-loaded hydrogels remains 
water. Important to note, the prolongation of the aqueous 
CUR solubility was observed irrespective whether CUR was 
directly solubilized by H100 (Figure 3a, gray bars) or incorpo-
rated as nanoformulation (blue, red, black bars). Furthermore, 
this remarkable long-term stability was found irrespective of 
the chemical structure of the triblock copolymers. Similarly, 
an extraordinary suppression of crystallization was previously 
observed in nanoformulations of paclitaxel using A-BuOx-
A.[71] HPLC analysis suggests that no CUR degradation 
occurred as the ratio between the curcuminoids bisdemeth-
oxycurcumin (BDMC), demethoxycurcumin (DMC) and CUR 
remained constant during 22 months storage (Figure 3b,c) 
which reportedly shifts during degradation processes.[73] 
Hennink and co-workers previously reported that polymer 
micelles can stabilize CUR in water by several orders of mag-
nitude, but they still clearly observed degradation within a few 
days.[69] As all samples showed comparable loading and long-
term stabilities, the rheological properties of all CUR loaded 
hydrogels were determined as described in the following.
Macromol. Chem.  Phys. 2020, 221, 1900341
Figure 3. a) Solubilized aqueous CUR concentrations in dependence of the CUR feed (x-axis) by H100 (20 wt% in H2O) after preparation (full bars) 
or 22 months storage at 8 °C under the exclusion of light (hollow bars). CUR was either directly solubilized by H100 (gray) or pre-incorporated into 
polymer micelles of A-BuOx-A (blue), A-BuOzi-A (red), or A-PrOzi-A (black). Concentration of the ABA triblock-copolymers is given by purple num-
bers (mg/ghydrogel,wet); b) corresponding HPLC elugrams after 22 months storage at λabs = 220 nm to exclude CUR degradation. Elugrams of neat 
H100 (bottom, gray) and CUR (2nd bottom, orange) are given for comparison. Numbers left of the elugrams correspond to amount of ABA triblock-
copoly mer/CUR (mg/ghydrogel,wet); c) detailed view of the HPLC elugrams at λabs = 427 nm as well as d) corresponding ratio of BDMC, DMC, and CUR.
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3.2. Rheological Properties
3.2.1. CUR-Loaded Hydrogels
Addition of hydrophobic CUR strongly affected the thermore-
sponsive and viscoelastic properties of H100-based hydrogels 
(Figure 4). Especially at low CUR feed concentrations of 7.5 or 
15 mg/g, Tgel significantly increased from 20 °C (neat H100; 
20 wt%) to 45 and 42 °C, respectively. Accordingly, the storage 
modulus (G′) at 37 °C strongly decreased several magnitudes 
from 3.4 kPa (0 mg/g CUR) to 24 Pa (7.5 mg/g) and 39 Pa 
(15 mg/g). Clearly, incorporation of CUR significantly weak-
ened the gel structure at same strain. Arguably, both trends are 
disadvantageous for the intended use as injectable drug depot, 
as Tgel should be below body temperature forming a gel with 
sufficient strength to prevent rapid dissolution/dispersion of 
the depot. A decrease in G′ to 253 Pa (37 °C) was also observed 
at 30 mg/g CUR feed, whereas Tgel decreased to 16 °C. How-
ever, this gel remained rather weak with pronounced viscous 
character as the loss factor (tan δ = G″/G′) remained close to 
unity. In any case, CUR clearly interferes significantly with the 
formation of a physically crosslinked polymer network neces-
sary for gelation.
Similar trends of decreasing gel stiffness with increasing 
drug-content were also observed for other hydrogels such 
as poly-(d,l-lactic acid-co-glycolic acid) (PLGA)-poly ethylene 
glycol (PEG)-PLGA.[27] In this report, G′max (T ≈ 35 °C) 
decreased from 520 to 280 and 250 Pa by incorporation of 
0, 4, and 8 g L−1 docetaxel (DTX), respectively. It should be 
mentioned that a dramatic decrease of G′ to essentially 0 Pa 
at T > 37 °C occurred for both, the neat as well as the DTX-
loaded hydrogel. Nevertheless, a single intratumoral injec-
tion of DTX-containing hydrogel was as efficient as three IV 
injections of DTX. In a different report, a decrease in max-
imum viscosity (ηmax, 37 °C) with increasing drug content for 
doxorubicin (0.6 g L−1 DOX)[25] as well as PTX (2 g L−1 PTX)[26] 
loaded PEG-b-polycaprolactone (PEG-PCL)-based hydro-
gels was observed. In another report, the gelation of PLGA-
PEG-PLGA was completely prevented by the incorporation 
of 1.6 g L−1 rapamycin. Interestingly, this strong interfer-
ence could be suppressed by co-solubilization of two other 
hydrophobic drugs, paclitaxel and tanespimycin (17-AAG).[22] 
While the incorporation of hydrophobic drugs in various 
hydrogels consistently decreased gel stiffness, the influence 
on Tgel appeared to be rather small without a trend, as Tgel 
sometimes slightly increased,[19,25,26] and sometimes slightly 
decreased.[27]
However, we wondered if CUR addition in form of CUR 
nanoformulations[54] could prevent the detrimental interference 
with the gel, retaining the initial viscoelastic properties of H100.
3.2.2. Incorporation of ABA Triblock Copolymers into 
Hydrogel Matrix
Prior to the incorporation of CUR nanoformulations, the influ-
ence of the ABA triblock copolymers alone on the gelation 
properties of H100 is of interest. At low polymer concentrations 
of 25 mg/g hydrogel, only minor changes of the thermogelling 
properties of H100 occurred (Figure 5a). In the case of A-BuOzi-
A and A-PrOzi-A, Tgel slightly increased to 23 and 25 °C respec-
tively, whereas it remained constant in the case of A-BuOx-A. 
In case of A-PrOzi-A, the storage modulus (G′) was reduced 
somewhat throughout the investigated temperature range 
(G′ = 2.2 kPa (37 °C)), whereas it increased slightly through 
the incorporation of polymers bearing butyl side chains. The 
increase was most pronounced for A-BuOx-A with G′ = 4.7 kPa 
(37 °C). The trend of decreasing Tgel and increasing gel stiff-
ness became more prominent with increasing A-BuOx-A con-
centration. At A-BuOx-A = 50 mg/g, G′ increased by a factor 
of two to 6.8 kPa (37 °C) (Figure 5b). Tgel decreased further 
to 17 °C, whereas G′ kept increasing to 7.8 kPa (37 °C) when 
100 mg/g A-BuOx-A were added (Figure 5c). At this point, the 
total polymer concentration was 27 wt%. However, the decrease 
in Tgel and increase of G′ was not simply due to an increase in 
solids content, as shown in the case of A-BuOzi-A and A-PrOzi-
A. At both, 50 and 100 mg/g triblock copolymer concentration, 
A-BuOzi-A as well as A-PrOzi-A increased Tgel and decreased 
gel stiffness (Figure 5b,c). This was most pronounced for 
A-PrOzi-A. As the latter comprises the same building blocks as 
H100, it seems reasonable that A-PrOzi-A interfered most with 
the gelation of H100. As both, hydrophilic and hydrophobic 
block are identical and the degree of polymerization does 
not differ very much, these two polymers should be expected 
to mix freely. Since the self-assembly of block copolymers 
does strongly depend on the block volume ratio, this must be 
expected to affect the self-assembly and thus, thermogelation 
of H100. A-BuOzi-A, sharing the same backbone but bearing a 
more hydrophobic central B block still interferes significantly, 
albeit somewhat less with the gelation of H100. Even though 
being intermediate with respect to hydrophobicity, A-BuOx-A 
exhibits an entirely different influence on the thermogelation of 
H100. At this point, we can only assume that the different back-
bone (POx vs POzi) of the hydrophobic block reduces mixing, 
Macromol. Chem.  Phys. 2020, 221, 1900341
Figure 4. Temperature dependent rheological analysis of H100 (20 wt%) 
before (gray) and after solubilization of 7.5 (orange), 15 (pink) or 30 
(brown) mg/g CUR. Samples were heated from 5 to 60 °C at 5 °C min−1. 
Frequency was 1 Hz at 0.5% amplitude. Tgel is defined as the crossover 
of storage G′ (lines with symbols) and loss modulus G″ (lines without 
symbols).
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and therefore, does not influence network formation of H100 
as much. The lower Tgel and higher G′ may be explained by 
macromolecular crowding and competition for water molecules 
for hydration. Similarly, Tgel of thermoresponsive Pluronic F127 
gel (18 wt%) also decreased from 27.4 to 25.8 and 23.1 °C when 
incorporating 0.21%, 0.42%, and 1.24% w/v phospholipid-
based liposomes, respectively.[17] This was attributed to dehy-
dration of F127 micellar cores due to entrapment of water in 
the inner hydrophilic core of the liposomes leading to a greater 
extend of dehydration and lower Tgel.
Important to note, A-BuOx-A, being the only polymer 
to decrease Tgel and increase G′, was also the only ABA tri-
block copolymer exhibiting a thermogelling behavior on its 
own, albeit only at 20 wt%, and rather high temperatures 
Tgel = 41 °C. Also, the resulting gel was very weak with a low 
G′ (G′50 °C = 180 Pa) (Figure S21, Supporting Information). As 
a control to test the macromolecular crowding hypothesis, we 
also investigated the influence of PMeOx homopolymer with a 
DP of 100, approximately corresponding to the overall length 
of the ABA block copolymers. PMeOx was incorporated into 
H100 at the same concentrations as it is present incorporating 
the respective triblock copolymers at 25, 50, and 100 mg/g 
(Figure 5d). Interestingly, the PMeOx exhibited a weakening 
effect very similar to the one of A-PrOzi-A, yielding comparable 
temperature-dependent rheological profiles, sol–gel transition 
temperatures as well as gel stiffnesses. This, in combination 
with the difference between PMeOx and, for example, A-BuOx-
A once more highlights the influence of the hydrophobic block 
of the respective triblock copolymers. Next, it was interesting 
to investigate how the incorporation of CUR nanoformulations 
of the different triblock copolymers affect the thermoresponsive 
behavior of H100.
3.2.3. Incorporation of CUR Nanoformulations of ABA Triblock 
Copolymers into Hydrogel Matrix
In contrast to neat CUR or neat polymers, the incorporation of 
CUR and polymer in form of nanoformulations of A-BuOx-A, 
A-BuOzi-A, or A-PrOzi-A affected the viscoelastic properties to 
a lesser extent (Figure 6). Overall, Tgel was either comparable 
or lower than that of neat H100 (20 wt%). This suggests that 
the CUR nanoformulations remain largely intact during their 
dissolution in H100. Having a distinct core–shell structure in 
mind, all CUR loaded micelles present the same hydrophilic 
PMeOx corona, somehow masking the influence of the dif-
ferent hydrophobic cores (Figure 5a–c).
That such core–shell structure is probably not a fully accu-
rate representation of the actual micellar morphology becomes 
evident when considering the remaining small differences 
between the hydrogels incorporating different CUR nanofor-
mulations suggesting a small but noticeable effect of the hydro-
phobic block on the hydrogel properties. We recently reported 
that in fact the hydrophilic corona is involved in the binding of 
CUR in this system.[74] Similar to the incorporation of the neat 
triblock copolymers, A-BuOx-A/CUR exhibited the highest gel 
Macromol. Chem.  Phys. 2020, 221, 1900341
Figure 5. Temperature dependent rheological analysis of H100 (20 wt%) before (gray) and after addition of a) 25; b) 50; or c) 100 mg/g of A-BuOx-A 
(blue), A-BuOzi-A (red), or A-PrOzi-A (black); d) incorporation of PMeOx homopolymer (DP = 30) at the same polymer concentration as it would be 
present by the incorporation of ABA triblock-copolymers at 25, 50, and 100 mg/g. Samples were heated from 5 to 60 °C at 5 °C min−1. Frequency was 
1 Hz at 0.5% amplitude. Tgel is defined as the intersection of storage G′ (lines with symbols) and loss modulus G″ (lines without symbols).
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stiffness at a given temperature, whereas G′ of A-PrOzi-A/CUR 
was still below that of neat H100.
To verify the reproducibility of our observations, we synthe-
sized a second batch of H100 and investigated its rheological 
properties (Figure S22a, Supporting Information). More impor-
tantly, also the influence of A-PrOzi-A/CUR at both, the lowest 
(25/7.5 mg/gH100,wet; Figure S22b, Supporting Information) and 
highest solids content (50/30 mg/gH100,wet, Figure S22c, Sup-
porting Information), was highly reproducible using the dif-
ferent batch of H100. A-PrOzi-A/CUR was either added as dry 
powder to 20 wt% H100 (as employed above) or added as highly 
concentrated aqueous solution (A-PrOzi-A/CUR = 150/90 or 
75/22.5 g/L) to 30 wt% H100 to yield the same final polymer, 
CUR and hydrogel concentrations. Although the latter prepara-
tion method is faster, aqueous polymer/drug concentrations of 
150/90 g/L may not be generally feasible with most systems.
The differences between the various nanoformulations were 
also apparent by the flow properties of the respective hydrogels, 
as H100 + A-BuOx-A/CUR exhibited shape integrity already at 
15 °C, whereas A-BuOzi-A/CUR or A-PrOzi-A/CUR were free-
flowing sols under the same conditions (Figure 7a), despite 
rheological analysis might suggest otherwise (G′ < G″ for all 
samples at 15 °C, Figure 7b). Nevertheless, all hydrogels incor-
porating CUR nanoformulations exhibited sol–gel transitions 
well below body temperature as well as sufficient stability at 
37 °C, making them promising candidates as injectable drug 
depots. Therefore, the CUR release of selected hydrogels was 
investigated in the next step.
3.2.4. CUR Release from Hydrogels Embedded in Collagen
To investigate the CUR release under conditions related to the 
desired application as injectable, subcutaneous drug depot, 
the CUR-loaded hydrogels were injected into a collagen matrix 
embedded on the apical side of trans-well inserts and subse-
quently the CUR release determined on the basolateral side. 
Collagen was chosen since it reflects the composition and 
structure of human connective tissue to which drug-loaded 
hydrogels might be applied in a future clinical setting. In pre-
liminary experiments, we noticed major variabilities in the 
drug release profile, which we attributed to variation of the 
positioning of the hydrogel depot within the collagen matrix. To 
reduce such variations, the syringes containing the CUR-loaded 
hydrogels were guided using a 3D-printed scaffold to ensure 
reproducible injection depth (0.25 cm at 0.5 cm height of col-
lagen) as well as injection position (Figure 8a). Before injection, 
the syringes loaded with the respective hydrogels were cooled 
for 20 min at 8 °C to ensure liquidity of the respective sols. 
CUR was either neatly incorporated into the hydrogel (20 wt% 
H100 + 15 mg/g CUR) or in the form of A-PrOzi-A (polymer/
CUR = 50/30 mg/g) or A-BuOx-A (polymer/CUR = 50/15 mg/g) 
nanoformulations, both at maximum CUR-loadings. These 
hydrogels were selected due to their different gel properties. 
Whereas H100 directly incorporating CUR exhibited a sol–gel 
transition above body-temperature (Tgel = 42 °C; G′37°C = 37 Pa; 
Figure 4), both hydrogels incorporating triblock-copolymers are 
solid gels at the investigated 37 °C (Figure 6c,d). Interestingly, 
Macromol. Chem.  Phys. 2020, 221, 1900341
Figure 6. Temperature dependent rheological analysis of H100 (20 wt%) before (gray) and after incorporation of CUR-loaded polymer micelles of 
A-BuOx-A (blue), A-BuOzi-A (red), or A-PrOzi-A (black). Concentration of polymer/CUR added was either a) 25/7.5; b) 25/15; c) 50/15; or d) 50/30 mg/
gH100,wet. Samples were heated from 5 to 60 °C at 5 °C min−1. Frequency was 1 Hz at 0.5% amplitude. Tgel is defined as the intersection of storage G′ 
(lines with symbols) and loss modulus G″ (lines without symbols).
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Figure 7. a) Flow properties of H100 (20 wt% in H2O) incorporating CUR-loaded polymeric micelles (polymer/CUR = 50/15 mg/g) at either 15 (top) 
or 25 °C (bottom); b) corresponding rheological properties of respective hydrogels.
Figure 8. a) Setup for CUR release studies from CUR-loaded hydrogels or CUR-loaded polymer micelles injected into a collagen matrix. Hydrogel was 
added in a Hamilton syringe, cooled to 8 °C and subsequently injected (10 µL) into a transwell containing collagen. To ensure same injection depths 
and positions within the collagen matrix, the syringe was guided with a 3D printed scaffold (right picture); b) long-term CUR release of CUR directly 
incorporated into H100 (20 wt%; red curve) or pre-incorporated into either A-BuOx-A (polymer/CUR = 50/15 mg/g; blue curve) or A-PrOzi-A (polymer/
CUR = 50/30 mg/g, black curve). A-PrOzi-A/CUR at either polymer/CUR = 250/30 mg/g (green) or 50/30 mg/g (pink) without H100 for comparison; 
c) appearance of collagen matrix before (left) and 2 h (middle) or 2 days (right) after injection of H100/A-PrOzi-A/CUR (representative for all hydrogel 
containing samples); d) appearance of collagen containing H100/A-PrOzi-A/CUR (left) or A-PrOzi-A/CUR = 250/30 mg/g (right) after 26 days incuba-
tion in PBS; e) collagen matrix initially containing H100/A-PrOzi-A/CUR after release experiment (d 69); f) aqueous CUR concentration in basolatoral 
chamber released per day; g) concentration of released CUR with respect to CUR aqueous solubility (= oversaturation) at day of quantification. All 
CUR-loaded samples were prepared once and injected in three individual trans-wells containing collagen. Results are presented as mean ± SD (n = 3).
www.advancedsciencenews.com www.mcp-journal.de
© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900341 (11 of 13)Macromol. Chem.  Phys. 2020, 221, 1900341
H100/CUR exhibited the fastest CUR-release of all samples 
(Figure 8b, red curve). Nevertheless, a sustained release was 
obtained with 50% CUR release after approximately 15 days 
(t50%). H100 incorporating A-BuOx-A/CUR at the same CUR 
concentration of 15 mg/g (blue curve) exhibited a slower 
release profile, with t50% = 19 days. This may be attributed to 
the much stronger network, as evidenced by their rheological 
properties (G′37°C(H100/CUR) = 37 Pa; G′37°C(H100/A-BuOx-A/
CUR) = 5.7 kPa). The slower release in the presence of A-BuOx-
A could also be due to altered pore sizes of the respective 
hydrogel which might to some extent correlate with the gel 
stiffness. To investigate this hypothesis, more detailed inves-
tigations utilizing, for example, fluorescence recovery after 
photo bleaching would be necessary, which are outside the 
scope of the current contribution.
A more sustained release of acetylsalicylic acid (AS) pre-
incorporated into lipid nanoparticles compared to directly sol-
ubilized AS also occurred for κ-carrageenan-based hydrogels 
within the first 2 h after immersing the respective hydrogels 
in water.[66] However in contrast to the presently reported find-
ings, the cumulative release within 40 h of directly solubilized 
AS was much lower than that of formulated one reaching a 
plateau already after 15 h (= incomplete overall drug release). 
Unfortunately, the influence of the nanoformulation on gela-
tion properties was not further investigated in this report. 
Similarly, Nie et al.[17] observed a prolonged release of PTX pre-
incorporated into liposomes compared to solubilization of neat 
PTX with Pluronic F127 at both, the dialysis method (20% vs 
40% release after 8 h) as well as when immersing the gels in 
water (60% vs 90% release after 8 h).
H100 incorporating A-PrOzi-A/CUR (Figure 8b, black curve) 
exhibited the longest release profile with 50% release after 
approximately 23 days and 80% release after 36 days. As the dif-
ferences between H100 incorporating either A-PrOzi-A/CUR or 
A-BuOx-A/CUR became evident only at later stage of 19 days 
and after, the longer release of the former is probably due to the 
higher CUR concentration in the case of A-PrOzi-A/CUR rather 
than the viscoelastic properties of the hydrogel (G′37°C(H100/A-
PrOzi-A/CUR) = 2.0 kPa). A similar faster cumulative release 
at lower drug-loading was also observed for PEG-PCL-PEG-
based hydrogels when immersed at 37 °C in PBS.[75] At 1 g L−1 
honokiol, 45% drug was released after 8 days, whereas only 
35% were released at 2 g L−1 in the same time period. Cumu-
lative release of honokiol reached a plateau already at day 8 
with little less than 50% overall release after 14 days, hinting 
toward drug crystallization/precipitation preventing further 
release. However, the release studies in this report were only 
performed once and conclusions should be regarded with great 
care. In accordance with the previous observations, a slower 
drug release also occurred for PLGA-PEG-PLGA-based hydro-
gels incorporating increasing amounts of DTX.[27] Cumula-
tive drug release after 3 weeks at 37 °C were 92% and 85% at 
2 and 8 g L−1 DTX, respectively. Similarly, cumulative release 
from PEG-PCL hydrogel was slower at 2 g L−1 PTX (30% after 
30 days) than at 1 g L−1 (40% after 30 days).[26]
Important to note, the CUR release from the drug-loaded 
hydrogels was essentially quantitative with overall CUR 
releases of ≥98%. In contrast, when injecting neat A-PrOzi-A/
CUR nanoformulations into collagen without incorporation 
into H100 at either the same nanoformulation concentra-
tion as present in H100 hydrogel (50/30 mg/g; pink curve) 
or at the same total polymer concentration (hydrogel + nano-
formulation, 250/30 mg/g; green curve), a strikingly different 
release profile occurred. At the latter, CUR release was fastest 
with half-life of 10 days. The slower CUR release at lower 
A-PrOzi-A concentration of 50 mg/g (pink curve) may be attrib-
uted to a non-homogenous distribution in the collagen matrix 
or a smaller excess of polymer carrier. Whereas A-PrOzi-A/
CUR = 250/30 mg/g enabled a decent overall release of 72%, 
only 36% of total added CUR was released from A-PrOzi-A/
CUR = 50/30 mg/g. Visual inspection of the respective col-
lagen samples revealed the reason for this incomplete release 
in the absence of H100. Immediately after injection, a more 
or less spherical depot is discernable at the injection site 
(Figure 8c, 1 h). After day 1, the yellow color of CUR distrib-
uted homogenously throughout the whole collagen matrix 
(Figure 8c, 2 days). This homogeneity remained throughout 
the whole release experiment in all samples containing H100. 
In contrast, without H100, precipitation of CUR occurred at 
a later stage (Figure 8d, right sample) correlating with the 
incomplete CUR release (Figure 8b, green and pink curves). 
This is quite interesting, as the nanoformulation A-PrOzi-A/
CUR itself exhibits excellent stability in aqueous media.[54] 
This suggests that the collagen matrix somehow destabilizes 
the nanoformulations while this was apparently not the case 
when using H100/CUR depots. This is of great importance 
regarding the desired application as injectable drug depot, as 
it enables sustained and complete release over long periods of 
time. Important to note, after the release experiments, as sug-
gested by the quantitative analysis, all collagen matrices ini-
tially containing H100 were completely colorless showing no 
sign of retained CUR (Figure 8e).
Important to note, only the CUR release of A-pPrOzi-A/
CUR directly incorporated into collagen without H100 showed 
a linear release profile at early timepoints (followed by plateau 
region) when plotted against square root of time (Figure S23b, 
Supporting Information). A linear trend is typical of the Fickian 
diffusion mechanism.[76] In contrast, when incorporated into 
H100, a sigmoidal CUR release was observed (Figure S23a, 
Supporting Information). The deviation from the often 
observed linear square root release kinetic of small compounds 
incorporated into hydrogel matrices might be due to the dual 
hydrogel system, that is, incorporation of drug-loaded hydrogel 
(H100) into another hydrogel (collagen). In case of the neat 
nanoformulations, the maximum CUR concentrations released 
per day were already reached at day 4 (Figure 8f). In contrast, 
employing H100 depots, released CUR concentration gradu-
ally increased up to day 8 (H100/CUR; H100/A-PrOzi-A/CUR) 
or day 11 (H100/A-BuOx-A/CUR), respectively, before they 
started to decrease. This can be attributed to the reduced dif-
fusivity in H100, prolonging the homogenous distribution of 
the respective gels in the collagen matrix. CUR concentrations 
well above CUR aqueous solubility of 1.6 µm (0.6 mg L−1[48]) 
were reached in all samples in the recipient chamber. There-
fore, we must assume that CUR was not released as free drug, 
but in solubilized form, presumably in the form of drug-loaded 
polymer micelles. In the case of the hydrogel incorporating 
A-PrOzi-A/CUR, a pronounced oversaturation with respect to 
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CUR aqueous solubility was achieved at day 11 ([CUR] = 47 µm, 
29-fold, Figure 8g, black curve) and the oversaturation extended 
for several weeks (e.g., 18-fold at day 36) suggesting the long-
term integrity of CUR nanoformulations in the collagen matrix. 
Important to note, the increase in CUR oversaturation from 
day 19 to day 36 is due to longer time intervals between sam-
pling of the basolateral solution (Figure 8g, black and blue 
curves). In terms of controlled release, the drug depot featuring 
the A-BuOx-A/CUR showed arguably the most promising per-
formance. The early-time concentration spike was less pro-
nounced and quite steady release was observed over the course 
of 30 days.
4. Conclusion
CUR was incorporated into a cytocompatible hydrogel either 
directly or in form of a nanoformulation for a prospective 
injectable drug depot. Solubilization of neat CUR strongly 
interfered with the gelation of the hydrogel while incorpora-
tion of neat polymer used in nanoformulations resulted in two 
opposing trends. The purely POx-based triblock copolymer 
increased gel stiffness as well as decreased Tgel, whereas poly-
mers bearing POzi-based hydrophobic cores similar or same to 
the one present in the hydrogel impeded the gelation process. 
Interestingly the influence of both, CUR and the neat poly-
mers, was strongly attenuated by incorporating both into the 
hydrogel matrix in form of CUR nanoformulations suggesting 
that the drug-loaded polymer micelles remain largely intact 
within the POx-based hydrogel. After injection into a collagen 
matrix used as a simple model for subcutaneous administra-
tion, all POx-based systems exhibited essentially quantitative 
CUR-release. Interestingly, CUR directly incorporated into 
the hydrogel showed the fastest cumulative release, whereas 
the CUR nanoformulations exhibit markedly prolonged drug 
release. This is in accordance with their viscoelastic proper-
ties. Even after 50 days, the concentration of released CUR 
was above the inherent CUR water solubility, illustrating the 
release of CUR in a solubilized form from this novel combined 
drug depot and delivery systems. Most interestingly, CUR-
loaded polymer micelles injected without hydrogel showed 
CUR precipitation in the collagen matrix. In contrast, col-
lagen containing CUR-loaded POx hydrogels showed no sign 
of CUR precipitation during 69 days of release experiment. 
These findings together with the extraordinary shelf life of the 
CUR-loaded hydrogels with no loss of CUR-content even after 
22 months make them an interesting platform as a combined 
drug depot and delivery system for, for example, subcutaneous 
or intraocular injections. As the presently investigated hydrogel 
has been demonstrated to be suitable as a bioink for 3D cell 
printing, we envision the combination of 3D cell bioprinting 
with 3D printed drug depots with extended release as potential 
future development.
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